About three months after Oregon Health&Science University suspended its Heart Transplant Program indefinitely, an outside peer review is scheduled to begin on Monday.

The peer review and assessment of the transplant program and Knight Cardiovascular Institute are “privileged, confidential and exempt from public disclosure,” although OHSU will share updates with the public, said spokeswoman Tamara Hargens-Bradley.

The health care profession often uses indep endent peer review to allow team…

Related Links:

Conclusion: The findings of the study showed that NGAL associated with NT-proBNP was a stronger predictor of the primary endpoint than NGAL or NT-proBNP alone. The level of NGAL was rising in hypertension, ischemia, anemia, hypoalbuminemia, diabetes or arrhythmias.Kidney Blood Press Res 2018;43:1865 –1877

Publication date: December 2018Source: Canadian Journal of Cardiology, Volume 34, Issue 12Author(s): Frank Battaglia, Lisa Mielniczuk, Vincent ChanAbstractWe provide an update on Canada’s first neonatal heart transplant recipient who, after cardiac retransplantation, underwent a mitral valve replacement and tricuspid valve repair. Twenty-seven years after his initial heart surgery and 13 years after his most recent transplant, this patient developed heart failure with severe mitral regurgitation secondary to a calcified mitral valve. The patient was highly sensitized with no evidence of allograft rejection; therefore…

We report identical diffuse subepicardial LGE in 2 highly allosensitized HT recipients who developed allograft failure. We postulate this LGE pattern may be related to antibody-mediated rejection and cardiac allograft vasculopathy, and portends poor outcomes. These cases illustrate a potential role of cardiac magnetic resonance for antibody-mediated rejection evaluation and risk stratification.RésuméLe rehaussement tardif après injection de gadolinium (RTG) observé à l’imagerie cardiaque par résonance magnétique est utile au pronostic chez les populations atteintes de …

We critically appraised all available evidence regarding exercise interventions for improving patient survival and reducing hospital admissions in adults with chronic heart failure (HF). We searched 4 databases up to April 2018 and graded the quality of evidence according to the Grading of Recommendations Assessment, Development and Evaluation working group approach. We reviewed 7 meta-analyses and the publications of 48 randomized controlled trials (RCTs). In HF with reduced ejection fraction, low-quality evidence suggests that exercise prevents all-cause hospitalizations [Relative risk (RR), 0.77; 95% confidence interval…

Source: Cardiology in ReviewCategory: Cardiology Tags: Review Articles Source Type: research

Conclusion: Our study reported a facile and effective approach to developing a functional ECP that was based on a mussel-inspired conductive nanofibrous membrane. This functional ECP could repair infarct myocardium through enhancing cardiac function and revascularization.

Source: TheranosticsCategory: Molecular Biology Authors: Tags: Research Paper Source Type: research

Heart transplantation is the definitive treatment for end-stage heart failure. A shortage of donor hearts forced transplant programs to accept older donors and longer ischemic times. Previous studies have suggested that the administration of mesenchymal stem cells (MSCs) or their conditioned medium (CM) protects the heart against ischemia/reperfusion injury (IRI). We hypothesized that the preservation of donor hearts with a CM would protect the graft from IRI after prolonged storage in 15-month-old rats and investigated mRNA-changes attributable to CM.

Source: The Journal of Heart and Lung TransplantationCategory: Transplant Surgery Authors: Tags: Original Pre-Clinical Science Source Type: research

Chronic lung allograft dysfunction (CLAD) affects over 50% of lung transplant recipients (LTR) by five years and remains the primary reason for graft failure 1. It has been increasingly recognized that CLAD is a heterogeneous diagnosis with variable prognosis and different phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). Precise diagnosis of CLAD remains difficult: There are no clinically-validated biomarkers, and diagnosis can be subjective, hinging on the correct interpretation of pulmonary function tests (PFTs) coupled with exclusion of clinical confounders.

Source: The Journal of Heart and Lung TransplantationCategory: Transplant Surgery Authors: Tags: RESEARCH CORRESPONDENCE Source Type: research

The added value of cardiopulmonary exercise testing (CPET) in the follow-up of patients with stable pulmonary arterial hypertension (PAH) remains undefined.

Source: The Journal of Heart and Lung TransplantationCategory: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research

Chronic lung allograft dysfunction (CLAD) is a major cause of post-lung transplant mortality with limited medical treatment options. We assessed the association of montelukast treatment with pulmonary function and outcome in lung transplant recipients with progressive CLAD.

Source: The Journal of Heart and Lung TransplantationCategory: Transplant Surgery Authors: Source Type: research

Right ventricular failure (RVF) is still associated with an increased mortality in patients with pulmonary hypertension (PH) or congenital heart disease. Transition from right ventricular dysfunction to RVF is not predictable and has not been well understood so far. Several studies in rodents and in piglets showed that impairment of capillary density (CD) in the right ventricle (RV) is associated with right ventricular failure (1, 2). Some evidence suggested that the RV of patients with Eisenmenger Syndrome (ES) has remarkable adaptive capacities to high pulmonary pressures (3), leading to a longer survival in these patien…

Source: The Journal of Heart and Lung TransplantationCategory: Transplant Surgery Authors: Tags: Research Correspondence Source Type: research

Source link


Please enter your comment!
Please enter your name here